First, targeting the key pathways that regulate the behaviour of CRC‐SCs – including WNT, NOTCH, EGFR and TGF‐beta/BMP – is an obvious approach to prevent the maintenance or expansion of this cell population. This evidence concerns the gene EGFR and colorectal carcinoma.